Download A4Medicine Mobile App
Empower Your RCGP AKT Journey: Master the MCQs with Us! π
Acute Left Ventricular Failure (ALVF) is a sudden inability of the left ventricle (LV) to pump blood effectively to meet the body's metabolic needs.
Leads to:
Pulmonary congestion (fluid in lungs)
Systemic hypoperfusion (poor blood supply to organs)
Potential progression to acute heart failure syndromes or cardiogenic shock
Pathophysiology:
β Myocardial contractility (weakened heart muscle)
Impaired diastolic filling (stiff ventricle)
Acute hemodynamic shifts due to:
Ischaemia
Arrhythmias
Hypertensive crisis
Valvular emergencies
Key Causes of Acute Left Ventricular Failure (ALVF)
Cause | Mechanism / Impact |
---|---|
Acute Myocardial Infarction (AMI) | Myocardial necrosis β β Contractility β Cardiogenic shock |
Coronary Artery Disease (CAD) | Chronic ischaemia β Progressive LV dysfunction |
Hypertensive Crisis | Acute β Afterload β LV strain & decompensation |
Valvular Heart Disease | Acute MR/AR β Volume overload β LV failure |
Arrhythmias (AF, VT) | Rapid/irregular rhythms β β Cardiac Output (CO), dyssynchrony |
Stress Cardiomyopathy (Takotsubo) | Catecholamine surge β Transient LV dysfunction |
Myocarditis | Inflammation β Direct myocardial injury β β Pump function |
Decompensated Chronic Heart Failure | Worsening of stable CHF due to triggers (e.g., infection, arrhythmia) |
Pulmonary Embolism (Massive) | Severe hypoxia + RV strain β β LV preload |
Sepsis / Severe Infections | Systemic inflammatory response β β Myocardial contractility |
Toxins / Drugs | Alcohol, cocaine, chemotherapy agents β Direct cardiac toxicity |
Volume Overload | Rapid fluid or sodium excess β β Preload β LV overload |
Thyrotoxicosis | β Metabolic demand β High-output state β LV decompensation |
Additional Mechanism Ventricular Interdependence: RV failure / Pulmonary Hypertension β β LV preload due to septal shift (Harjola et al., 2016).
The right ventricle (RV) and left ventricle (LV) share a common wall β the interventricular septum β and are both enclosed within the pericardium (heart's outer layer).
If the RV fails (e.g., due to pulmonary hypertension = β pressure in lungs), this can:
Dilate the RV: The RV enlarges as it struggles to pump against high lung pressures.
Shift the septum towards the LV: This physically compresses the LV chamber.
β LV filling (preload): The LV gets less blood during diastole (relaxation phase), reducing stroke volume.
β Cardiac Output: Less blood pumped out to the body β worsened systemic hypoperfusion.
In massive pulmonary embolism: sudden RV strain β septal shift β acute LV underfilling β shock & hypotension.
π This is why right heart problems can rapidly worsen left heart function, even if the LV itself isn't initially diseased.
Clinical Features of Acute Left Ventricular Failure (ALVF)
Symptom | Pathophysiology Explanation |
---|---|
Sudden-onset dyspnoea (breathlessness) | LV failure β β left atrial & pulmonary capillary pressure β pulmonary interstitial & alveolar oedema β impaired gas exchange & hypoxia. |
Orthopnoea | Worsens when lying flat due to redistribution of blood to the lungs, increasing pulmonary venous return and congestion. |
Paroxysmal nocturnal dyspnoea (PND) | Recumbency during sleep β gradual pulmonary fluid accumulation β awakens patient gasping for air. |
Fatigue, weakness, confusion | Systemic hypoperfusion β β oxygen delivery to muscles & brain β fatigue, weakness, altered mentation. |
Cough with frothy, pink-tinged sputum | Severe pulmonary oedema β leakage of fluid + RBCs into alveoli β pink, frothy sputum. |
Signs & Explanations
Sign | Mechanism |
---|---|
Tachypnoea | Compensatory response to hypoxia & acidosis from impaired gas exchange. |
Tachycardia | Sympathetic activation to maintain cardiac output in response to β stroke volume. |
Bilateral basal crackles | Pulmonary oedema causes fluid accumulation in alveoli, most evident at lung bases. |
Hypotension | Occurs if cardiac output severely compromised (e.g., cardiogenic shock). |
Hypertension | Seen in hypertensive crisis-induced ALVF due to excessive afterload. |
Cold, clammy skin | Peripheral vasoconstriction as a compensatory mechanism to preserve central circulation during hypoperfusion. |
Raised JVP (jugular venous pressure) | If right heart strain or RV failure coexists (ventricular interdependence), venous return backs up. |
S3 Gallop Rhythm | Indicates rapid ventricular filling against a stiff or failing LV, heard as an extra diastolic heart sound. |
Risk Factors: Previous heart failure (HF), myocardial infarction (MI), hypertension, valvular disease.
Triggers: Recent infections, non-compliance with HF meds, fluid overload, or new medications (e.g., NSAIDs).
Symptoms:
Sudden-onset breathlessness
Orthopnoea, paroxysmal nocturnal dyspnoea
Fatigue, confusion
Vital Signs:
BP: Hypotension or hypertension
Pulse: Tachycardia
RR: Tachypnoea
SpO2: Hypoxia if <92%
Signs of Pulmonary Oedema:
Bilateral crackles, wheeze
Signs of Systemic Congestion:
Peripheral oedema
Raised JVP
Hepatomegaly (if right heart failure)
Pulse Oximetry: Detect hypoxia early.
ECG:
Arrhythmias (e.g., AF, VT)
Ischaemia
LV hypertrophy
Blood Tests:
BNP / NT-proBNP: Elevated = heart failure likely.
Electrolytes & renal function: Assess for precipitating factors & safety of medications.
Troponin: If MI suspected.
Chest X-ray (if available):
Pulmonary oedema (Bat's wing appearance)
Cardiomegaly
Pleural effusions
Point-of-Care Ultrasound (POCUS):
Detect lung congestion
Evaluate LV function
Useful if trained personnel available.
π Early recognition and referral to secondary care is essential if ALVF is suspected, especially if there are signs of hypoxia, hypotension, or shock.
Key Differentials to consider
Differential Diagnosis | Distinguishing Features |
---|---|
Acute Coronary Syndrome (ACS) | Chest pain, ECG changes (ST elevation, Q waves), β Troponin, chest pain dominant |
Pulmonary Embolism (PE) | Sudden dyspnea, pleuritic chest pain, hypoxia, clear lungs, Wells score risk assessment |
Pneumonia | Fever, productive cough, unilateral crackles, consolidation on X-ray, β CRP/WCC |
COPD Exacerbation | Wheeze, prolonged expiration, smoking history, no pulmonary edema, normal BNP |
Acute Asthma Exacerbation | Wheeze, β Peak flow, younger patients, reversible with bronchodilators, normal BNP |
Pneumothorax | Sudden dyspnea, unilateral reduced breath sounds, hyper-resonance, asymmetrical chest findings |
Pericardial Effusion / Tamponade | Hypotension, raised JVP, muffled heart sounds, pulsus paradoxus, ECG: low voltage |
Anxiety / Panic Attack | Dyspnea without hypoxia, normal ECG, no crackles, psychological stress, younger age |
ARDS | Severe hypoxia, bilateral crackles, rapid onset post-infection/trauma, normal BNP |
Aortic Dissection | Sudden severe chest/back pain, unequal pulses/BP, widened mediastinum on X-ray, high-risk profile |
Acute Kidney Injury / Fluid Overload | Oliguria, recent nephrotoxin use, metabolic derangements, volume overload signs |
Cirrhosis / Nephrotic Syndrome | Ascites, peripheral edema, stigmata of liver disease, proteinuria |
The management of acute left ventricular failure (ALVF) in primary care settings necessitates a multifaceted approach that addresses the underlying causes, alleviates symptoms, and stabilizes the patient. The initial management should focus on prompt diagnosis and implementation of early therapeutic strategies to reduce morbidity and mortality associated with this condition.
Management Table for Acute LVF
Category | Key Actions |
---|---|
1. Immediate Stabilisation | - Sit patient upright (45β90Β°) - Oxygen therapy: if SpO2 <92% (aim 94β98%) - IV Diuretics: Furosemide 40 mg IV - Nitrates: GTN (if systolic BP >90 mmHg) - Avoid: Beta-blockers, NSAIDs, IV fluids |
2. Initial Pharmacological Treatment | - Loop diuretics: Ongoing use for symptom relief - Nitrates: Further doses as needed for preload reduction - Analgesia/Anxiolytics: E.g., low-dose morphine (rare, for severe distress only) |
3. Referral & Specialist Care | - Urgent hospital admission: especially if SpO2 <90%, hypotension, or chest pain. - Advanced care: Inotropes, vasodilators, ventilatory support, specialist review for further diagnostics & management |
π Beta-blockers, ACE inhibitors, and ARBs are introduced in stable patients post-admission under specialist guidance.
Faster onset of action: IV furosemide works within 5β15 mins, essential for rapid decongestion.
More reliable absorption: Acute LVF may impair gut perfusion, reducing oral drug absorption.
Potent diuresis: Immediate and more controlled fluid removal to relieve pulmonary oedema.
Too slow: Oral furosemide onset is 60β120 mins, inadequate for acute distress.
Unpredictable effect: Variable absorption in acute illness.
Once patient is stable post-admission, oral diuretics may be prescribed to:
Maintain fluid balance
Prevent re-accumulation of fluid
Transition from IV to oral therapy before discharge
If IV access is unavailable, and the patient is mildly symptomatic, a high-dose oral diuretic might be cautiously used while arranging urgent hospital admission.
But in true acute pulmonary oedema or severe ALVF, immediate hospital transfer for IV therapy is critical.
Patient Education:
Salt restriction:
Fluid restriction: Typically 1.5β2L/day (adjust based on clinical advice)
Smoking cessation & alcohol moderation
Daily weight monitoring: Early detection of fluid retention
Symptom awareness: Prompt reporting of dyspnoea, swelling, weight gain
Vaccination:
Annual influenza vaccine
One-off pneumococcal vaccine
Start/Up-titrate:
ACE inhibitors (or ARBs if intolerant) β β afterload, improve survival
Beta-blockers: Once stable, reduce risk of future decompensation
Mineralocorticoid Receptor Antagonists: E.g., spironolactone if LVEF β and symptoms persist (specialist guidance)
Consider SGLT2 inhibitors in line with latest heart failure guidelines (if applicable)
Specialist HF clinic review: Tailored medication titration, echocardiography monitoring
Renal function & electrolytes: Regular monitoring, especially on diuretics or MRAs
Rehabilitation: Heart failure rehab programmes to improve exercise tolerance and quality of life
Acute LVF requires rapid stabilisation and urgent referral.
Primary care supports long-term management: education, prevention, and medication adherence.
Follow national guidelines for ongoing care to reduce readmissions and improve outcomes.
National Institute for Health and Care Excellence (NICE). (2018). Chronic heart failure in adults: diagnosis and management (NG106).
https://www.nice.org.uk/guidance/ng106
National Institute for Health and Care Excellence (NICE). (2014). Acute heart failure: diagnosis and management (CG187).
https://www.nice.org.uk/guidance/cg187
McDonagh TA, et al. (2021). 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal, 42(36), 3599β3726.
https://doi.org/10.1093/eurheartj/ehab368
Ezekowitz JA, et al. (2022). Reduction of dietary sodium to less than 100 mmol in heart failure (SODIUM-HF). The Lancet, 399(10333), 1391β1400.
https://doi.org/10.1016/S0140-6736(22)00369-5
Mahtani KR, et al. (2020). Dietary sodium restriction in heart failure: a systematic review and meta-analysis. European Journal of Heart Failure, 22(7), 1148β1158.
https://doi.org/10.1002/ejhf.1880
Gupta D, et al. (2021). Fluid restriction in heart failure: a review of the evidence. Heart Failure Reviews, 26(4), 845β852.
https://doi.org/10.1007/s10741-020-10049-8
Heidenreich PA, et al. (2022). 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. Journal of the American College of Cardiology, 79(17), e263βe421.
https://doi.org/10.1016/j.jacc.2021.12.012
Brater DC. (1998). Diuretic therapy. New England Journal of Medicine, 339(6), 387β395.
https://doi.org/10.1056/NEJM199808063390607
Rodriguez M, et al. (2019). Cardiogenic shock. Future Medicine: Future Cardiology, 11(6).
https://doi.org/10.37532/fmic.2019.11(6).641
Templin C, et al. (2015). Clinical features and outcomes of Takotsubo (stress) cardiomyopathy. New England Journal of Medicine, 373(10), 929β938.
https://doi.org/10.1056/NEJMoa1406761
Ninagawa J, Yamada Y. (2010). General anesthesia in a patient with Parkes Weber syndrome with high-output cardiac failure. Journal of Anesthesia, 24(2), 256β259.
https://doi.org/10.1007/s00540-010-0875-8
Jourdain M, et al. (2010). Acute heart failure due to transient left ventricular dyssynchrony: case study. American Journal of Critical Care, 19(3), e12βe14.
https://doi.org/10.4037/ajcc2010310
Harjola VP, et al. (2016). Contemporary management of acute right ventricular failure. European Journal of Heart Failure, 18(3), 226β241.
https://doi.org/10.1002/ejhf.478
Rossano JW. (2015). Clinical management of patients with acute heart failure. Cardiology in the Young, 25(S2), 67β73.
https://doi.org/10.1017/S1047951115000852
The Cardiology Advisor: Acute Heart Failure Overview.
https://www.thecardiologyadvisor.com/ddi/acute-heart-failure/
Spinar J, et al. (2023). Acute Heart FailureβAn update. European Heart Journal Supplements, 25(Suppl C): C276βC283.
https://academic.oup.com/eurheartjsupp/article-abstract/25/Supplement_C/C276/7143308
Geeky Medics: Acute Heart Failure Summary.
https://geekymedics.com/acute-heart-failure/
McCarthy CP, et al. (2023). Acute heart failure: update on management.
https://pmc.ncbi.nlm.nih.gov/articles/PMC10132568/
Wikipedia: Heart Failure.
https://en.wikipedia.org/wiki/Heart_failure
StatPearls: Heart Failure Overview.
https://www.ncbi.nlm.nih.gov/books/NBK537098/
Medscape: Heart Failure Differential Diagnosis.
https://emedicine.medscape.com/article/163062-differential
ESC Resource: Acute Heart Failure Chapter.
https://www.escardio.org/static-file/Escardio/Medias/associations/acute-cardiovascular-care-association/AcuteCVDays/Acut%20Heart%20Failure%20Chapter%204.pdf
Cleveland Clinic: Left-Sided Heart Failure.
https://my.clevelandclinic.org/health/diseases/22181-left-sided-heart-failure
NICE Clinical Knowledge Summary: Heart Failure - Chronic.
https://cks.nice.org.uk/topics/heart-failure-chronic/
Local Guidelines and Resources:
Derbyshire: Heart Failure Guidelines
Cheshire: Heart Failure Guidelines